cerebral hemorrhage
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ? meet the diagnostic criteria of spontaneous intracerebral hemorrhage ? supratentorial intracerebral hemorrhage (bleeding volume 20ml-40ml) ? 18 years old = age =80 years old ? within 72 hours of onset ? 6 points = NIHSS score =25 points ? Glasgow Coma Scale (GCS) score =10 points ? patients or legal representatives gave informed consent and signed the informed consent form
Exclusion criteria
Exclusion criteria: ? Known to be allergic to Naoxueshu oral liquid or related drug ingredients ? previous history of stroke with modified Rankin scale (mRS) score =2 before the onset of the current stroke ? Previous history of lobar hemorrhage "(4) known causes of trauma, cerebral amyloid angiopathy, vascular malformation, aneurysm, coagulopathy, anticoagulation, or antiplatelet therapy. Drug therapy, thrombolytic therapy, cerebral infarction, hematologic disease, moyamoya disease, spontaneous or metastatic tumor, venous sinus thrombosis, "Cerebral hemorrhage due to vasculitis, pregnancy, or other definite causes. ? Primary intraventricular hemorrhage ? patients with active gastrointestinal ulcer or other definite rebleeding tendency ? Patients with severe heart, liver, kidney dysfunction, or other life-threatening diseases had a low expected survival time After 1 year ? Patients who have received or plan to undergo surgical treatment ? Pregnant, planning pregnancy, or breastfeeding women ? those currently participating in other interventional clinical trials
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 90-day functional prognosis; | — |
Secondary
| Measure | Time frame |
|---|---|
| 90-d all-cause mortality;edema volume;NIHSS score;Self-reported outcome;90d mRS;life quality score;Pharmacoeconomic evaluation; | — |
Countries
China
Contacts
Beijing Tiantan Hospital affiliated to Capital Medical University